GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Short-Term Capital Lease Obligation

Destiny Pharma (LSE:DEST) Short-Term Capital Lease Obligation : £0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma Short-Term Capital Lease Obligation?

Destiny Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.00 Mil.


Destiny Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Destiny Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma Short-Term Capital Lease Obligation Chart

Destiny Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Destiny Pharma Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Destiny Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Destiny Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Destiny Pharma (LSE:DEST) Business Description

Industry
Traded in Other Exchanges
Address
Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines